GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » Price-to-Free-Cash-Flow

HUMDF (Hua Medicine) Price-to-Free-Cash-Flow : N/A (As of May. 02, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Price-to-Free-Cash-Flow?

As of today (2025-05-02), Hua Medicine's share price is $0.15. Hua Medicine's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.06. Hence, Hua Medicine's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Hua Medicine's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 9 years, Hua Medicine's highest Price-to-Free-Cash-Flow Ratio was 2.40. The lowest was 1.17. And the median was 1.54.

HUMDF's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 23.05
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Hua Medicine's Free Cash Flow per Share for the six months ended in Dec. 2024 was $-0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.06.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Hua Medicine was -146.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -1.80% per year.

During the past 9 years, Hua Medicine's highest 3-Year average Free Cash Flow per Share Growth Rate was 36.50% per year. The lowest was -71.80% per year. And the median was 10.50% per year.


Hua Medicine Price-to-Free-Cash-Flow Historical Data

The historical data trend for Hua Medicine's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine Price-to-Free-Cash-Flow Chart

Hua Medicine Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - 2.00 -

Hua Medicine Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.00 - -

Competitive Comparison of Hua Medicine's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Hua Medicine's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hua Medicine's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hua Medicine's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hua Medicine's Price-to-Free-Cash-Flow falls into.


;
;

Hua Medicine Price-to-Free-Cash-Flow Calculation

Hua Medicine's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.15/-0.059
=N/A

Hua Medicine's Share Price of today is $0.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hua Medicine's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Hua Medicine  (OTCPK:HUMDF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Hua Medicine Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hua Medicine's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Hua Medicine Business Description

Traded in Other Exchanges
Address
Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203
Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.

Hua Medicine Headlines